Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Hosted on MSN24d
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024.The FDA cited deficiencies in the company’s manufacturing ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
Nanowear announced that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose ...
DexCom DXCM received a warning letter ... Abbott's FreeStyle Libre continuous glucose monitoring system (CGM) has seen significant growth, with sales surpassing $1.8 billion in the fourth quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback